BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2020
View Archived Issues
Initial phase I data presented for BFCR-4350A in relapsed/refractory multiple myeloma
Read More
Mouse model of malformations of cortical development and epilepsy
Read More
Positive topline data from pivotal phase III study of setmelanotide in BBS and Alstrom syndrome
Read More
Phase III DOM-INNATE trial of SGX-942 does not show statistically significant benefit
Read More
FDA approves Ebanga for the treatment of Zaire ebolavirus
Read More
Ultimovacs initiates phase II FOCUS study of its universal cancer vaccine in head and neck cancer
Read More
Emory University patents legumain inhibitors
Read More
IFM Due discloses hSTING receptor antagonists
Read More
Inflammatory protein can distinguish between good and bad microbes
Read More
Merck & Co. identifies new coagulation factor XIa inhibitors
Read More
Genentech and Roche present new bacterial SpsB and/or LepB inhibitors
Read More
Ultragenyx Pharmaceutical discovers new HFE-expressing polynucleotides
Read More
Cord blood-derived Treg product CK-0801 safe and beneficial in clinical trial
Read More
GBT-021601 improves the pathophysiology of sickle cell disease in vivo
Read More
FDA accepts IND for CERC-007 for Still's disease
Read More
FDA places clinical hold on RESTORE-1 trial of NBIb-1817
Read More
PKLR activator mitapivat shows promising preclinical data in murine hereditary spherocytosis
Read More
Disease-modifying anle-138b enters phase Ib study in patients with Parkinson's disease
Read More
New humanized graft-versus-host disease mouse model supports NK cell engraftment
Read More
FDA approves Kineret to treat deficiency of IL-1 receptor antagonist
Read More
Phase III study of SPN-812 for adult ADHD meets primary endpoint
Read More
SOURCE trial of tezepelumab in severe asthma misses primary endpoint
Read More
FDA places clinical hold on uniQure's hemophilia B gene therapy program
Read More
BioCryst reports part 1 data from clinical trial of galidesivir in COVID-19
Read More
Acticor initiates phase II trial of glenzocimab to treat COVID-19 related ARDS
Read More